Offered by: Nemours Children's
Locations: Pensacola, Fla.
DINAMO-Diabetes study of linagliptin and empagliflozin in children and adolescents
This study is for research purposes only and will help to gain information for providing better or new treatments for people in the future. This is different from regular medical care, where the purpose is to help each individual person.
Adolescents aged 10-17 years old with Type 2 diabetes that meet all entry criteria and are able to swallow pills. You must also agree to blood draws, to participate.
During this study you will be asked to:
This study is a 58 week study with 11 study visits.
Trial Name: Dinamo-Diabetes study of linagliptin and empagliflozin in children and adolescents
IRB#: 1223178
Learn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.